Rivian is on a mission to keep the world adventurous forever. We believe there is a more responsible way to explore the world and are determined to make the transition to sustainable transportation an exciting one. We designed our emissions-free Electric Adventure Vehicles to challenge what's possible.

Worked on multiple product development projects for an array of clients.Tatum Robotics January 2023-April 2023• Developed wearable device as an assistive technology to deafblind individuals using ERMs for tactile communication • Produced ready for market DFM solution through advanced prototyping and thorough analysisHot Date Kitchen: August 2022-December 2022• Created, prototyped, and iterated 100+ part custom industrial date cutting machine to automate production for client needs• Modeled and built fully modular machinery with high torque drive system, manufactured parts, and intuitive control panel• Conducted FEA on potential mechanical failures and increased client’s expected production capabilities by 200%CRATE: December 2021-May 2022• Collaborated with a team of 4 engineers to design a reusable anti-theft shipping solution for market applications in Fusion360• Designed 4 iterations of electro-mechanical assemblies for rapid prototyping using FDM and SLA 3D printing• Optimized solenoid locking mechanism to produce a 60% more compact and 30% power efficient variation

• Built a network of makers across southern California to 3D print, manufacture, assemble, and distribute 100,000 face shields to healthcare workers and at-risk communities across 17 states and 4 countries• Designed through SolidWorks a two-piece rapidly assembled, laser cut, face shield• Fabricated and validated design success through ensuring directed aerosolized droplets were deflected with 80% success• Received NIH approval for use in clinical settings by submitting technical documentation and tolerance analysis

• Utilized MATLAB to produce and model architectural features of angiogenic formation in solid malignant tumors• Discovered methodologies to replicate patterns of polarization in endothelial tip cells and correlated response to vascular endothelial growth factor to develop guidelines for targeted antiangiogenic therapeutics